Angina News and Research RSS Feed - Angina News and Research

Angina is chest pain or discomfort that occurs when an area of your heart muscle doesn't get enough oxygen-rich blood. Angina may feel like pressure or squeezing in your chest. The pain also may occur in your shoulders, arms, neck, jaw, or back. It can feel like indigestion.
New study to examine genomics of anti-platelet therapy after coronary interventions

New study to examine genomics of anti-platelet therapy after coronary interventions

Which antiplatelet medication is best after a coronary stent? The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) Study examines whether prescribing heart medication based on a patient's CYP2C19 genotype will help prevent heart attack, stroke, unstable angina, and cardiovascular death in patients who undergo percutaneous coronary intervention (PCI), commonly called angioplasty. [More]
Diabetic patients experience long-term survival outcomes with TAR/CABG surgery

Diabetic patients experience long-term survival outcomes with TAR/CABG surgery

Diabetic patients who undergo heart bypass surgery are living longer and have much better long-term outcomes when cardiothoracic surgeons use arteries rather than veins for the bypasses, according to a new study published online today by The Annals of Thoracic Surgery. [More]
Metabolic syndrome, cardiovascular events linked to decreased sexual activity in postmenopausal women

Metabolic syndrome, cardiovascular events linked to decreased sexual activity in postmenopausal women

Understanding the effects of age and disease on sexual wellbeing is crucial as sexual health is increasingly associated with vitality. In a new study published in The American Journal of Medicine, researchers looked at the role metabolic syndrome and cardiovascular disease play in postmenopausal women's sexual health. [More]
European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year. [More]
miRNAs may improve risk prediction in CAD

miRNAs may improve risk prediction in CAD

Single microRNAs derived from peripheral blood predict cardiovascular mortality in patients with coronary artery disease, German research shows. [More]
Ticagrelor drug shows minor added benefit for patients with history of myocardial infarction

Ticagrelor drug shows minor added benefit for patients with history of myocardial infarction

The German Institute for Quality and Efficiency in Health Care assessed the added benefit of ticagrelor for patients with acute coronary syndrome already in 2011 in its very first dossier assessment, just after the Act on the Reform of the Market for Medicinal Products had come into force. [More]
FDA approves Absorb GT1 BVS to treat coronary artery disease

FDA approves Absorb GT1 BVS to treat coronary artery disease

The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease. [More]
Post-MI angina linked to increased late readmission risk

Post-MI angina linked to increased late readmission risk

US researchers are calling for greater surveillance and treatment of post-myocardial infarction angina after their findings show an increased risk of late readmission among patients with angina symptoms at 30 days. [More]
Study links whole grain consumption to positive health effects

Study links whole grain consumption to positive health effects

Eating three more portions of dietary fiber a day--say, two pieces of whole grain bread and a bowl of whole grain breakfast cereal--is associated with a lower risk for all cardiovascular diseases and for dying of cancer, diabetes, and respiratory and infectious diseases, a study just published in the BMJ has shown. [More]
CHD rates decrease significantly in the U.S.

CHD rates decrease significantly in the U.S.

Significant improvements seen across multiple sociodemographic groups, according to a new study in the American Journal of Preventive Medicine [More]
Female migraine patients have increased cardiovascular disease risk

Female migraine patients have increased cardiovascular disease risk

Women who suffer from migraine headaches have a slightly increased risk of developing cardiovascular disease in later life. A team of researchers led by Prof. Tobias Kurth, Head of the Institute of Public Health at Charité - Universitätsmedizin Berlin, has now been able to establish the following: female migraine patients have a higher risk of stroke or heart attacks than women without migraine. [More]
Mortality risk high among diabetes patients with prior CV events

Mortality risk high among diabetes patients with prior CV events

Patients with Type 2 diabetes and acute coronary syndromes have a substantially increased risk of death in the 18 months after hospital admission for subsequent major nonfatal cardiovascular events, US researchers report. [More]
Diabetes-heart disease combination can increase death risk

Diabetes-heart disease combination can increase death risk

The combination of type 2 diabetes and coronary artery disease can be deadly. New research from a global study led by a physician from UConn Health has found that patients with Type 2 diabetes admitted into the hospital for congestive heart failure face a one in four chance of dying over the next 18 months. [More]
Common angina drug can stimulate patient's own white blood cells to combat cryptococcosis

Common angina drug can stimulate patient's own white blood cells to combat cryptococcosis

A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis [More]
CD34+ cell therapy improves angina frequency in no option patients with class III/IV angina refractory

CD34+ cell therapy improves angina frequency in no option patients with class III/IV angina refractory

A two-year, multi-center clinical study with 167 patients with class III-IV refractory angina randomized to low and high dose CD34+ cells or placebo has revealed that patients who received either a high or low dose of CD34 -- a member of a family of proteins that have an impact on vascular-associated tissue -- cells had a significant reduction in angina frequency over patients who received placebo. [More]
Migraine increases vascular disease risk in women

Migraine increases vascular disease risk in women

Women with migraine have a 50% increased risk of major cardiovascular disease, suggests a cohort study of Nurses' Health Study II participants. [More]
CKD status does not affect health status outcomes after AMI

CKD status does not affect health status outcomes after AMI

Chronic kidney disease does not accentuate the decline in health status often experienced by patients after acute myocardial infarction, US study data show. [More]
Pre-procedural use of antiplatelet therapy becoming less routine in heart attack treatment

Pre-procedural use of antiplatelet therapy becoming less routine in heart attack treatment

Doctors worried about dangerous blood clots in patients undergoing a coronary artery procedure— such as angioplasty to treat a heart attack — will often administer antiplatelet therapy to head off complications. [More]
CMR 'may be preferable' to SPECT for CHD prognosis

CMR 'may be preferable' to SPECT for CHD prognosis

Long-term follow-up of the CE-MARC study suggests that cardiovascular magnetic resonance could be a better predictor of cardiovascular events than single-photon emission computed tomography in patients with coronary heart disease. [More]
Researchers highlight need for more tailored approaches to treating chronic obstructive pulmonary disease

Researchers highlight need for more tailored approaches to treating chronic obstructive pulmonary disease

Speakers at the recent REG 2016 Summit highlighted the need for more research into the nature and effectiveness of treatment for COPD (Chronic Obstructive Pulmonary Disease) in a real-world environment. [More]
Advertisement
Advertisement